Home › Funds › Frazier Life Sciences Management, L.P. › IRON

Frazier Life Sciences Management, L.P. position in IRON

DISC MEDICINE INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 1,354,852 shares of IRON (DISC MEDICINE INC) in its Q2 2026 13F filing — a position valued at US$99.1M, representing 2.16% of its reported portfolio and ranking #12 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed IRON holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.35M sh
Reported value held$99.09M
Portfolio Weight2.16%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s IRON position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in IRON in Q3 2023 at 655,000 shares (US$30.8M). The position peaked in Q4 2024 at 1,754,834 shares, worth US$111.3M. Across 12 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,354,852 shares valued at US$99.1M. Notable position changes include a 124% increase in Q2 2024 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 655.00K $30.77M New
Q4 2023 785.00K $45.34M Add
Q1 2024 785.00K $48.87M Hold
Q2 2024 1.75M $79.09M Add
Q3 2024 1.75M $86.23M Hold
Q4 2024 1.75M $111.26M Hold
Q1 2025 1.75M $87.11M Hold
Q2 2025 1.65M $87.64M Reduce
Q3 2025 1.44M $95.06M Reduce
Q4 2025 1.26M $100.06M Reduce
Q1 2026 1.35M $86.63M Add
Q2 2026 1.35M $99.09M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRON and 13F data

IRON (DISC MEDICINE INC) is a Health Care company. 41 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Atlas Venture Life Science Advisors, LLC (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRON

All IRON fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held IRON?

Frazier Life Sciences Management, L.P. has disclosed IRON holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Frazier Life Sciences Management, L.P.'s current position in IRON?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 1.35M shares of IRON (DISC MEDICINE INC), valued at $99.09M, representing 2.16% of its reported portfolio and ranking #12.

Has Frazier Life Sciences Management, L.P. been buying or selling IRON?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in IRON. The position peaked in Q4 2024 at 1.75M shares.

Which other funds hold IRON?

Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.